A phase 2 randomised controlled trial published in the New England Journal of Medicine (2023) reported substantial weight loss and improvements in glycaemic parameters, though the trial was conducted in a closely monitored clinical setting with defined eligibility criteria
Additional information Sodium Palmate, Sodium Palm Kernelate, Water, Glycerin, Fragrance, Sodium Chloride, Disodium Cocoamphodiacetate, Titanium Dioxide/Cl 77891, Tetrasodium Etidronate, Tetrasodium EDTA, Butylene Glycol, 1,2-Hexanediol, Glutathione
Ipamorelin has therefore appeared in research examining neuroendocrine regulation and circadian hormone release
Pete rated this product a 5 out of 5 for first impressions
Sign up now to enjoy the discount
Follow handling protocols meticulously